Article Details

After setbacks for Roche and Sanofi, AZ scores oral SERD win - - Pharmaphorum

Retrieved on: 2022-10-26 10:23:01

Tags for this article:

Click the tags to see associated articles and topics

After setbacks for Roche and Sanofi, AZ scores oral SERD win - - Pharmaphorum. View article details on hiswai:

Excerpt

AstraZeneca seems to have dodged the problems besetting other developers of oral selective estrogen receptor degrader (SERD) drugs with a phase 2 ...

Article found on: pharmaphorum.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up